共 31 条
[1]
Abraham M A, 1999, J Assoc Physicians India, V47, P862
[2]
AUSTIN HA, 1984, KIDNEY INT, V25, P689, DOI 10.1038/ki.1984.75
[3]
COMPLEMENT ACTIVATION DURING SYSTEMIC LUPUS-ERYTHEMATOSUS - C3A AND C5A ANAPHYLATOXINS CIRCULATE DURING EXACERBATIONS OF DISEASE
[J].
ARTHRITIS AND RHEUMATISM,
1986, 29 (09)
:1085-1089
[4]
ASSESSMENT OF DISEASE-ACTIVITY AND IMPENDING FLARE IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS - COMPARISON OF THE USE OF COMPLEMENT SPLIT PRODUCTS AND CONVENTIONAL MEASUREMENTS OF COMPLEMENT
[J].
ARTHRITIS AND RHEUMATISM,
1992, 35 (09)
:1028-1037
[6]
Collins AB, 1999, J AM SOC NEPHROL, V10, P2208
[9]
THE TERMINAL COMPLEMENT COMPLEX, C5B-9, A MARKER OF DISEASE-ACTIVITY IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
[J].
ARTHRITIS AND RHEUMATISM,
1988, 31 (02)
:188-195